Supplementary Figure S11 from Ctdna Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or Without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial
crossref(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined